Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
33
NCT05111353
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery
Phase: Phase 1
Role: Collaborator
Start: Dec 15, 2022
Completion: Nov 3, 2025